Delivery Order SPE2DB25D7068-SPE2DB25FTWNJ
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,678.96, is for the delivery of 4,567,873,264 units of the medication Ondansetron ODT 4 mg tablet. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,426.64, is for the delivery of 4,568,012,975 units of the medication Ondansetron HCL 4 mg tablet. It is a firm fixed-price, non-set-aside contract with a performance period through April 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,167.93, is for the delivery of 4,563,362,847 units of the medication Ondansetron ODT 4 mg tablets. The contract is a Firm Fixed Price, has no set-aside designation, and has a completion date of January 22, 2024. AmerisourceBergen holds a $999,999,999 IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,255,117 units of Ondansetron ODT 4 mg tablets. The firm-fixed-price contract has a ceiling value of $3,609.81 and a completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,957.59, is for the delivery of 4,567,908,925 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The contract is a firm fixed-price delivery order, without any set-aside designation, with a completion date of April 15, 2025. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,930.66 firm fixed-price contract is for the purchase of 4,563,753,739 units of the drug Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of February 26, 2024 and was awarded on February 23, 2024. There was no set-aside designation for this award. AmerisourceBergen holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,093,137 units of Ondansetron ODT 4 mg tablets, with a firm fixed price ceiling value of $2,158.78. The contract has an ultimate completion date of May 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,078.32, is for the delivery of 4,567,926,097 units of the medication Ondansetron HCL 4 mg tablets. The contract is a firm fixed-price, non-set-aside arrangement with a performance period ending on April 16, 2025. AmerisourceBergen also holds a $999,999,999.00 Indefinite Delivery...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,715.35 fixed-price contract is for the delivery of 4,563,432,604 units of ondansetron ODT 4 mg tablets. The IDC has a potential value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,895.46, is for the delivery of 4,568,077,758 units of Ondansetron HCl 4 mg tablets in 30-count packages. The contract is a firm-fixed price delivery order, with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...